• 00:00 1.
    index 1
  • 00:26 2.
    Slide 2
  • 01:29 3.
    CircRNA expression profiles in NSCLC and characterization of circACVR2A
  • 02:28 4.
    CircRNA expression profiles in NSCLC and characterization of circACVR2A
  • 03:02 5.
    Slide 5
  • 03:05 6.
    CircRNA expression profiles in NSCLC and characterization of circACVR2A
  • 03:24 7.
    Slide 5
  • 04:15 8.
    Slide 6
  • 04:54 9.
    Slide 7
  • 06:01 10.
    Slide 8
  • 06:34 11.
    Prostate Cancer (PC)
  • 07:21 12.
    Genetic Alterations and Treatment Approaches of PC
  • 08:08 13.
    Mechanism of Androgen Receptor (AR)
  • 08:47 14.
    Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
  • 09:22 15.
    Prostate Cancer Resistance Mechanisms
  • 10:05 16.
    Heterogeneous Patterns of Resistance Mechanisms
  • 10:52 17.
    Biological Functions of Long Non-coding RNA (lncRNA)
  • 11:35 18.
    Slide 16
  • 12:12 19.
    IRX4-AS1 Upregulated in Prostate Cancer
  • 13:30 20.
    The Characteristic of IRX4-AS1
  • 14:37 21.
    IRX4-AS1 had Lower Protein Coding Probability
  • 15:21 22.
    Slide 20
  • 15:48 23.
    Knockdown IRX4-AS1 Inhibit Cell Proliferation
  • 16:25 24.
    Knockdown IRX4-AS1 Increased Cell Viability after SG-ARA Treatment
  • 17:01 25.
    Slide 23
  • 17:31 26.
    IRX4-AS1 has Binding Potential with AR
  • 18:12 27.
    IRX4-AS1 didn’t bind with AR
  • 18:58 28.
    IRX4-AS1 has Binding Potential with miRNA
  • 19:47 29.
    Slide 27
  • 20:05 30.
    Knockdown IRX4-AS1 Increased the Level of AR mRNA and AR Protein
  • 21:16 31.
    Knockdown IRX4-AS1 Increased the Level of Canonical Gene
  • 21:58 32.
    The Characteristic of C4-2 SG-ARA resistant
  • 23:18 33.
    The Characteristic of C4-2 SG-ARA resistant
  • 23:34 34.
    IRX4-AS1 downregulated in SG-ARA resistant cells
  • 24:10 35.
    Slide 33
  • 24:28 36.
    Slide 34
  • 25:47 37.
    Thank you for listening
  • 26:12 38.
    Slide 34
  • 26:45 39.
    Genetic Alterations and Treatment Approaches of PC
  • 28:28 40.
    Mechanism of Androgen Receptor (AR)
  • 28:31 41.
    Prostate Cancer Resistance Mechanisms
  • 28:56 42.
    Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
  • 28:56 43.
    Mechanism of Androgen Receptor (AR)
  • 28:56 44.
    Genetic Alterations and Treatment Approaches of PC
  • 28:57 45.
    Prostate Cancer (PC)
  • 28:57 46.
    Slide 8
  • 28:58 47.
    Slide 7
  • 29:00 48.
    Slide 6
  • 29:06 49.
    Slide 5
  • 29:20 50.
    Slide 7
  • 30:30 51.
    Knockdown IRX4-AS1 Increased the Level of Canonical Gene
  • 35:02 52.
    IRX4-AS1 didn’t bind with AR
  • 36:24 53.
    IRX4-AS1 downregulated in SG-ARA resistant cells
  • 38:23 54.
    Slide 7
  • 39:08 55.
    Prostate Cancer (PC)
  • 40:56 56.
    ** after 20240430_林俐妤seminar_V2-3.pptx
  • Index
  • Notes
  • Comment
  • Fullscreen
20240415 lab meeting_俐妤
Duration: 41:05, Browse: 199, Last Updated: 2024-04-15
    • 00:00 1.
      index 1
    • 00:26 2.
      Slide 2
    • 01:29 3.
      CircRNA expression profiles in NSCLC and characterization of circACVR2A
    • 02:28 4.
      CircRNA expression profiles in NSCLC and characterization of circACVR2A
    • 03:02 5.
      Slide 5
    • 03:05 6.
      CircRNA expression profiles in NSCLC and characterization of circACVR2A
    • 03:24 7.
      Slide 5
    • 04:15 8.
      Slide 6
    • 04:54 9.
      Slide 7
    • 06:01 10.
      Slide 8
    • 06:34 11.
      Prostate Cancer (PC)
    • 07:21 12.
      Genetic Alterations and Treatment Approaches of PC
    • 08:08 13.
      Mechanism of Androgen Receptor (AR)
    • 08:47 14.
      Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
    • 09:22 15.
      Prostate Cancer Resistance Mechanisms
    • 10:05 16.
      Heterogeneous Patterns of Resistance Mechanisms
    • 10:52 17.
      Biological Functions of Long Non-coding RNA (lncRNA)
    • 11:35 18.
      Slide 16
    • 12:12 19.
      IRX4-AS1 Upregulated in Prostate Cancer
    • 13:30 20.
      The Characteristic of IRX4-AS1
    • 14:37 21.
      IRX4-AS1 had Lower Protein Coding Probability
    • 15:21 22.
      Slide 20
    • 15:48 23.
      Knockdown IRX4-AS1 Inhibit Cell Proliferation
    • 16:25 24.
      Knockdown IRX4-AS1 Increased Cell Viability after SG-ARA Treatment
    • 17:01 25.
      Slide 23
    • 17:31 26.
      IRX4-AS1 has Binding Potential with AR
    • 18:12 27.
      IRX4-AS1 didn’t bind with AR
    • 18:58 28.
      IRX4-AS1 has Binding Potential with miRNA
    • 19:47 29.
      Slide 27
    • 20:05 30.
      Knockdown IRX4-AS1 Increased the Level of AR mRNA and AR Protein
    • 21:16 31.
      Knockdown IRX4-AS1 Increased the Level of Canonical Gene
    • 21:58 32.
      The Characteristic of C4-2 SG-ARA resistant
    • 23:18 33.
      The Characteristic of C4-2 SG-ARA resistant
    • 23:34 34.
      IRX4-AS1 downregulated in SG-ARA resistant cells
    • 24:10 35.
      Slide 33
    • 24:28 36.
      Slide 34
    • 25:47 37.
      Thank you for listening
    • 26:12 38.
      Slide 34
    • 26:45 39.
      Genetic Alterations and Treatment Approaches of PC
    • 28:28 40.
      Mechanism of Androgen Receptor (AR)
    • 28:31 41.
      Prostate Cancer Resistance Mechanisms
    • 28:56 42.
      Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
    • 28:56 43.
      Mechanism of Androgen Receptor (AR)
    • 28:56 44.
      Genetic Alterations and Treatment Approaches of PC
    • 28:57 45.
      Prostate Cancer (PC)
    • 28:57 46.
      Slide 8
    • 28:58 47.
      Slide 7
    • 29:00 48.
      Slide 6
    • 29:06 49.
      Slide 5
    • 29:20 50.
      Slide 7
    • 30:30 51.
      Knockdown IRX4-AS1 Increased the Level of Canonical Gene
    • 35:02 52.
      IRX4-AS1 didn’t bind with AR
    • 36:24 53.
      IRX4-AS1 downregulated in SG-ARA resistant cells
    • 38:23 54.
      Slide 7
    • 39:08 55.
      Prostate Cancer (PC)
    • 40:56 56.
      ** after 20240430_林俐妤seminar_V2-3.pptx
    Location
    Folder name
    2024
    Author
    周楷軒
    Branch
    賴亮全教授
    Created
    2024-04-15 09:56:47
    Last Updated
    2024-04-15 10:16:21
    Duration
    41:05